Difficulty: Medium
Average Score: 87%
Practice
Children with end-stage renal disease (ESRD) are typically treated with either dialysis or renal transplantation when glomerular filtration rate is less than
Correct answer
A
Rationale
In pediatric patients with end-stage renal disease (ESRD), the glomerular filtration rate (GFR) is a crucial indicator of kidney function and the need for renal replacement therapy. The correct answer, A) 15 ml/min/1.73 m2, is the threshold at which children with ESRD are typically considered for either dialysis or renal transplantation.
Option B) 25 ml/min/1.73 m2 is higher than the typical GFR threshold for initiating renal replacement therapy in children with ESRD. Option C) 35 ml/min/1.73 m2 and Option D) 45 ml/min/1.73 m2 are even further above the threshold, indicating relatively preserved renal function that would not usually necessitate immediate intervention such as dialysis or transplantation.
Educationally, understanding the GFR threshold for initiating renal replacement therapy in pediatric ESRD is vital for nurses and healthcare providers caring for these vulnerable patients. This knowledge helps in timely intervention to prevent complications associated with advanced kidney disease and ensures optimal management to improve outcomes and quality of life for pediatric patients with ESRD.
Option B) 25 ml/min/1.73 m2 is higher than the typical GFR threshold for initiating renal replacement therapy in children with ESRD. Option C) 35 ml/min/1.73 m2 and Option D) 45 ml/min/1.73 m2 are even further above the threshold, indicating relatively preserved renal function that would not usually necessitate immediate intervention such as dialysis or transplantation.
Educationally, understanding the GFR threshold for initiating renal replacement therapy in pediatric ESRD is vital for nurses and healthcare providers caring for these vulnerable patients. This knowledge helps in timely intervention to prevent complications associated with advanced kidney disease and ensures optimal management to improve outcomes and quality of life for pediatric patients with ESRD.